XBXuejuan Bai

Xuejuan Bai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuejuan Bai has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Xueqiong Wu

    Army Tuberculosis Prevention and Control Key Laboratory, Beijng Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute for Tuberculosis Research, The 309th Hospital of Chinese PLA, Beijing 100091, PR China

    4 shared publications
  • Yourong Yang

    Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China

    4 shared publications
  • Junxian Zhang

    2 shared publications
  • Lan Wang

    Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, 100091 Beijing, China

    2 shared publications
  • Ning Li

    The 309th hospital of PLA

    2 shared publications
  • Qi Yu

    The 309th hospital of PLA

    2 shared publications

Latest Publications

  • Open Access

    Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice

    by Yan Liang, Xiaoyan Zhang, Xuejuan Bai, Li Xiao, Xiaomei Wang, Junxian Zhang, Yourong Yang, Jinying Song, Lan Wang, Xueqiong Wu

    Tuberculosis (TB) is a major global public health problem. New treatment methods on TB are urgently demanded. In this study, Mycobacterium tuberculosis (MTB) rv2190c DNA vaccine was prepared and its immunogenicity and therapeutic effects were evaluated. Non-infected mice immunized with rv2190c DNA or ag85a DNA showed higher levels of interferon-gamma (IFN-γ) in stimulated spleen lymphocyte culture supernatants, and had more Th1 cells and an elevatory ratio of Th1/Th2 immune cells in whole blood, indicating that Th1-type immune response was predominant. Compared with the saline group, ag85a DNA group and rv2190c DNA group in the infected mice decreased the lung colony-forming units (CFUs) by 0.533 and 0.283 log10, and spleen CFUs by 0.425 and 0.321 log10 respectively, and pathological lesion. The rv2190c DNA had some immunotherapeutic effect on TB.


  • Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models

    by Yan Liang, Xiaomei Wang, Jinying Song, Lan Wang, Dan Chen, Yourong Yang, Xuejuan Bai, Jie Wang, Yingchang Shi, Shibing Chen, et al.


    • 1 April 2015
      • Vol. 31  (4) , 474-7

    [Prediction of epitopes of Rv1410c Mycobacterium tuberculosis protein using DNAStar software].

    by Jiangying Li, Xuejuan Bai, Yan Liang, Junxian Zhang, Yourong Yang, Weiguo Zhao, Xueqiong Wu

    To predict the epitopes of Rv1410c Mycobacterium tuberculosis (MTB) protein. Rv1410c MTB amino acid sequence was saved and edited using Editseq software of DNAStar package, and then Protean software was used to analyze the amino acid sequence and predict the secondary structures, B cell epitopes and T cell epitopes of Rv1410c MTB. Finally, BLAST was utilized to assess its homology with human epitopes. The Rv1410c MTB protein had abundant secondary structures. It contained a higher proportion of potential B cell epitopes located at 1-10, 67-77, 129-137, 189-205, 222-235, 253-267, 296-306, 330-338, 359-367, 462-467, 494-517 amino acid residues or nearby. Theses epitopes contained beta angle structure mostly, presenting with better antigenicity, higher surface probability and flexibility. There were also several potential T cell epitopes located at 16-37, 84-102, 108-115, 137-160, 202-207, 219-222, 245-263, 321-325, 355-362, 387-391, 417-445, 486-494 amino acid residues or nearby. Rv1410c MTB protein contains both potential B cell antigen epitopes and potential T cell antigen epitopes.

    • 1 January 2015
      • Vol. 45  (1) , 39-48

    Immune responses to a recombinant Rv0057-Rv1352 fusion protein of Mycobacterium tuberculosis.

    by Yourong Yang, Jindong Feng, Junxian Zhang, Weiguo Zhao, Yu Liu, Yan Liang, Xuejuan Bai, Lan Wang, Xueqiong Wu

    The identification and characterization of antigens of Mycobacterium tuberculosis help in understanding the mechanisms of protective immunity and in improving diagnostic methods for TB. Rv0057 and Rv1352 proteins are new T-cell antigens, found to play roles in TB infection. In this study, a recombinant fusion protein Rv0057-Rv1352 was made and analyzed for its immunological characteristics and potential utility. It showed good immunoreactivity with serum from TB patients by western blotting. The antibody levels against Rv0057-Rv1352 were significantly higher in sera from 69 TB patients than in sera from 60 patients with non-TB respiratory diseases (P0.05). These results suggest that Rv0057-Rv1352 has potential for the serodiagnosis of active pulmonary TB.


  • Primary ovarian trabecular carcinoid tumor: a case report and literature review

    by Xuejuan Bai, Ning Li, Fenghua Wang, Shulin Li, Qi Yu

    Carcinoid tumors are uncommon neoplasms in the diffuse peripheral endocrine system. Ovarian carcinoids are rare and can be primary or transplanted. Primary ovarian carcinoids make up approximately 0.5–1.7% of all carcinoid tumors.


    • 1 May 2009
      • Vol. 38  (5) , 353-4

    [Renal papillary adenoma in transplant donor kidney: report of a case].

    by Xue-Juan Bai, Min Yang, Qi Yu, Ning Li